As an oncologist with over 15 years of experience treating breast cancer patients, I've witnessed firsthand the challenges faced by those with advanced hormone receptor-positive (HR+) and HER2-negative (HER2-) disease. Endocrine therapies have long been a cornerstone of treatment, but resistance often develops, leaving patients with limited options. That's why the recent approval of Entinostat...
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bangla